ArticleBrain and behavior2026
Causal Exposures of Immune Cells in Neuromyelitis Optica Spectrum Disorders: A Mendelian Randomization Study and Flow Cytometry Analysis.
Article in Brain and behavior, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundNeuromyelitis optica spectrum disorders (NMOSD) are an immune-mediated inflammatory disease of the central nervous system (CNS) primarily characterized by anti-aquaporin-4 immunoglobulin G (AQP4-IgG)-mediated astrocyte injury, neuroinflammation, and demyelination. However, the relationship between the disease and the immune trait from a genetic perspective still requires further confirmation.
methodsThis study used two-sample Mendelian randomization (MR) to assess causal relationship of immune cells with NMOSD. A total of 731 immune phenotyping traits were considered as exposure factors. NMOSD group is defined as outcome factor, which single-nucleotide polymorphisms (SNPs) obtained from the study of Karol Estrada et al. (n = 215 NMOSD cases). The disease group was subcategorized into three groups based on the presence of AQP4-IgG or not. We then enrolled 27 NMOSD patients and 17 healthy controls for peripheral blood flow cytometric analyses to validate part of our findings.
resultsIn this study, we found multiple possible genetic associations between immune cells and NMOSD. Beyond the well-recognized roles of T and B cells, diverse myeloid-lineage cells may also contribute to NMOSD pathophysiology. For AQP4-IgG seropositive patient, myeloid cells, including dendritic cells (DCs) and the surface molecule CD80, granulocytic myeloid-derived suppressor cells (MDSCs), and the molecule CX3CR1 may have a protective role in this group. In AQP4-IgG seronegative patients, molecules like herpesvirus entry mediator (HVEM) exert pathogenic roles in NMOSD. Further flow-cytometric analysis revealed that the proportion of MDSCs in NMOSD patients was lower, consistent with the MR analysis. However, the phenotypic expression of CX3CR1 in our NMOSD cohort yielded results opposite to those of the MR analysis. Additionally, many immune traits were correlated with the clinical phenotypes of NMOSD patients. CONCLUSIO: Adaptive immune cells play significant role in NMOSD patients.Certain innate immune cells (e.g., DCs and MDSCs) and surface molecules (e.g., CX3CR1 and CD80) may correlate with certain clinical phenotypes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.